Rapid Dose Therapeutics Corp. reported earnings results for the first quarter ended May 31, 2022. For the first quarter, the company reported sales was CAD 0.061766 million compared to CAD 0.823748 million a year ago.

Net loss was CAD 1.01 million compared to CAD 0.160335 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.002 a year ago.